Serotonin 5-HT


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 11 2019
Historique:
received: 28 01 2019
accepted: 21 10 2019
entrez: 15 11 2019
pubmed: 15 11 2019
medline: 13 11 2020
Statut: epublish

Résumé

A non-synonymous single nucleotide polymorphism of the human serotonin 5-HT

Identifiants

pubmed: 31723224
doi: 10.1038/s41598-019-53124-2
pii: 10.1038/s41598-019-53124-2
pmc: PMC6853916
doi:

Substances chimiques

Receptor, Serotonin, 5-HT2C 0
Serotonin Receptor Agonists 0
Serotonin 333DO1RDJY
Serine 452VLY9402
Cysteine K848JZ4886
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

16737

Subventions

Organisme : NIDA NIH HHS
ID : P50 DA033935
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007287
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002649
Pays : United States

Références

Mol Psychiatry. 2001 Jul;6(4):373-9
pubmed: 11443520
Pharmacol Rep. 2011;63(1):45-53
pubmed: 21441610
J Cell Biol. 1984 Feb;98(2):399-406
pubmed: 6693488
Cell. 1984 Jul;37(3):789-800
pubmed: 6204769
Psychopharmacology (Berl). 2008 Nov;200(4):487-96
pubmed: 18597077
Genomics. 1995 May 20;27(2):274-9
pubmed: 7557992
Neuropharmacology. 2011 Sep;61(3):513-23
pubmed: 21575646
Curr Opin Cell Biol. 2011 Feb;23(1):85-93
pubmed: 21071196
Neuroscience. 2016 Jun 2;324:50-61
pubmed: 26926963
Nature. 2017 Jun 8;546(7657):312-315
pubmed: 28514449
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):1021-8
pubmed: 15953671
Mol Pharmacol. 2008 Mar;73(3):748-57
pubmed: 18083778
Hum Psychopharmacol. 2011 Aug;26(6):365-72
pubmed: 21717509
J Cell Sci. 1995 Mar;108 ( Pt 3):1275-85
pubmed: 7622610
Mol Psychiatry. 2004 Jan;9(1):55-64
pubmed: 14699441
Pharmacopsychiatry. 2004 Nov;37(6):286-91
pubmed: 15551195
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17296-301
pubmed: 25404298
Biochem J. 1998 Aug 15;334 ( Pt 1):283-95
pubmed: 9693131
PLoS One. 2018 Aug 29;13(8):e0203137
pubmed: 30157263
Glycoconj J. 2014 Oct;31(6-7):417-26
pubmed: 25186198
J Cell Sci. 1998 Jan;111 ( Pt 1):45-60
pubmed: 9394011
Trends Pharmacol Sci. 2008 Sep;29(9):454-64
pubmed: 18676031
J Neurosci. 2012 Jul 4;32(27):9344-50
pubmed: 22764241
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:120-135
pubmed: 26739950
Nat Rev Mol Cell Biol. 2012 Apr 13;13(5):323-8
pubmed: 22498832
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):128-33
pubmed: 19032968
J Biol Chem. 2004 Jan 23;279(4):2945-54
pubmed: 14602721
Neuroreport. 1995 Dec 29;7(1):169-72
pubmed: 8742444
J Biol Chem. 1992 Dec 15;267(35):25196-201
pubmed: 1460019
Nat Protoc. 2014 Feb;9(2):312-22
pubmed: 24434800
J Cell Sci. 2001 Apr;114(Pt 8):1455-71
pubmed: 11282022
J Histochem Cytochem. 2003 Mar;51(3):349-61
pubmed: 12588963
Eur J Clin Pharmacol. 2011 Nov;67(11):1131-7
pubmed: 21614492
Mol Psychiatry. 2007 Sep;12(9):797-8
pubmed: 17767148
Annu Rev Pharmacol Toxicol. 2008;48:537-68
pubmed: 18184106
J Biol Chem. 2014 Jul 11;289(28):19477-90
pubmed: 24891503
Eur J Pharmacol. 2012 Jun 5;684(1-3):44-50
pubmed: 22497996
Biol Psychiatry. 2016 May 15;79(10):814-822
pubmed: 26248536
Biochimie. 2003 Mar-Apr;85(3-4):323-30
pubmed: 12770771
J Neurochem. 2010 Jun;113(6):1504-15
pubmed: 20345755
Mol Psychiatry. 2001 Sep;6(5):579-85
pubmed: 11526472
Pharmacol Biochem Behav. 2002 Apr;71(4):533-54
pubmed: 11888546
Neuropsychopharmacology. 2014 Jan;39(2):370-82
pubmed: 23939424
Trends Pharmacol Sci. 2013 Oct;34(10):560-70
pubmed: 24041919
Mol Biol Cell. 2008 Nov;19(11):4640-50
pubmed: 18768750
Br J Pharmacol. 2015 Jan;172(2):349-63
pubmed: 24527749
Mol Cell Endocrinol. 2011 Jan 15;331(2):205-14
pubmed: 20654691
ACS Chem Neurosci. 2015 Jul 15;6(7):1248-58
pubmed: 26120876
Pharmacogenomics J. 2005;5(4):244-54
pubmed: 15912142
Glycobiology. 2002 Apr;12(4):43R-56R
pubmed: 12042244
Obesity (Silver Spring). 2009 Mar;17(3):494-503
pubmed: 19057523
Traffic. 2009 Jan;10(1):116-29
pubmed: 19000170
Transl Psychiatry. 2014 Mar 11;4:e369
pubmed: 24618688
Eur J Pharmacol. 2017 Nov 15;815:138-146
pubmed: 28899696
J Neurochem. 2005 Jun;93(6):1603-15
pubmed: 15935077
J Neurosci. 2013 Jan 23;33(4):1615-30
pubmed: 23345234
Am J Physiol Cell Physiol. 2011 Apr;300(4):C723-42
pubmed: 21209361
Behav Pharmacol. 2007 Dec;18(8):791-800
pubmed: 17989517
Mol Psychiatry. 2008 Nov;13(11):1001-10
pubmed: 17848916
J Biol Chem. 1990 Jun 5;265(16):9264-71
pubmed: 2140570
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1681-5
pubmed: 8446582
Crit Rev Biochem Mol Biol. 1998;33(3):151-208
pubmed: 9673446
J Biol Chem. 1988 Feb 15;263(5):2452-9
pubmed: 3339018
Mol Biol Cell. 2006 Nov;17(11):4619-31
pubmed: 16914526
Pharmacogenomics. 2010 Nov;11(11):1561-71
pubmed: 21121776
J Biol Chem. 2000 Aug 4;275(31):23620-6
pubmed: 10816555
Nat Med. 2006 Mar;12(3):324-9
pubmed: 16474401
Expert Opin Ther Targets. 2004 Feb;8(1):15-23
pubmed: 14996615
EMBO J. 2013 May 15;32(10):1478-88
pubmed: 23584533
Mov Disord. 2000 Nov;15(6):1064-9
pubmed: 11104187
J Biol Chem. 1999 Aug 6;274(32):22303-12
pubmed: 10428799
EMBO J. 2002 May 15;21(10):2332-42
pubmed: 12006486
Eur J Cell Biol. 2012 Apr;91(4):294-9
pubmed: 21543132
J Cell Biol. 1991 Oct;115(1):151-64
pubmed: 1918133
Neuropsychopharmacology. 2001 May;24(5):478-91
pubmed: 11282248
Neuropharmacology. 2008 Nov;55(6):969-76
pubmed: 18602407
J Microsc. 2013 Dec;252(3):295-302
pubmed: 24117417
Prog Brain Res. 2008;172:7-44
pubmed: 18772026

Auteurs

Michelle A Land (MA)

Center for Addiction Research, Galveston, TX, USA.

Holly L Chapman (HL)

Center for Addiction Research, Galveston, TX, USA.
Department of Pharmacology and Toxicology, Galveston, TX, USA.

Brionna D Davis-Reyes (BD)

Center for Addiction Research, Galveston, TX, USA.

Daniel E Felsing (DE)

Center for Addiction Research, Galveston, TX, USA.
Department of Pharmacology and Toxicology, Galveston, TX, USA.

John A Allen (JA)

Center for Addiction Research, Galveston, TX, USA.
Department of Pharmacology and Toxicology, Galveston, TX, USA.

F Gerard Moeller (FG)

Center for Addiction Research, Galveston, TX, USA.
Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.

Lisa A Elferink (LA)

Center for Addiction Research, Galveston, TX, USA.
Department of Neuroscience, Cell Biology and Anatomy, University of Texas Medical Branch, Galveston, TX, USA.

Kathryn A Cunningham (KA)

Center for Addiction Research, Galveston, TX, USA.
Department of Pharmacology and Toxicology, Galveston, TX, USA.

Noelle C Anastasio (NC)

Center for Addiction Research, Galveston, TX, USA. ncanasta@utmb.edu.
Department of Pharmacology and Toxicology, Galveston, TX, USA. ncanasta@utmb.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH